Description
Benefits
Biome IBS™ Probiotic:
- Relieves the symptoms of medically diagnosed Irritable Bowel Syndrome
- Relieves abdominal bloating
- Promotes bowel regularity
Features
Shelf-stable; refrigeration not required
No added:
GMOs | wheat | gluten | dairy | lactose | fructose | yeast | nuts | seeds | peanut | soy | egg | fish | shellfish | animal derivatives
No artificial colours, flavours, sweeteners, or preservatives.
Suitable for vegetarians and vegans
Active Ingredients
| Each capsule contains: | |
| Lactobacillus plantarum 299v (DSM 9843) | 10 BLB* |
| Lactobacillus rhamnosus GG (ATCC 53103) | 10 BLB* |
| Bifidobacterium breve BR03 (DSM 16604) | 3 BLB* |
| Total live bacteria | 23 BLB* |
|
*BLB = Billion Live Bacteria |
Directions
Adults and children over 12 years: take 1 capsule daily (with or without food), or as directed by your healthcare practitioner.
Always read the label. Follow the directions for use.
Science
Irritable Bowel Syndrome (IBS) is a common gastrointestinal (GI) condition, causing symptoms including abdominal pain, bloating, and constipation and/or diarrhoea. Probiotics have been extensively studied in people with IBS, and have been found to be effective in reducing symptoms and improving quality of life(1). Biome IBS™ Probiotic combines two of the most effective probiotic strains studied in people with IBS: Lactobacillus plantarum 299v and Lactobacillus rhamnosus GG. The benefit of these two probiotic strains has been proven through a number of randomised, double-blind, placebo-controlled clinical trials in both children and adults(2-7).
References
- Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol. 2015 Mar 14;21(10):3072–84.
- Ducrotté P, Sawant P, Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol WJG. 2012 Aug 14;18(30):4012–8
- Niedzielin K, Kordecki H, Birkenfeld B ena. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. European Journal of Gastroenterology & Hepatology [Internet]. 2001;13(10).
- Nobaek S, Johansson M-L, Molin G, Ahrné S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. The American journal of gastroenterology. 2000;95(5):1231–1238.
- Pedersen N, Andersen NN, Végh Z, Jensen L, Ankersen DV, Felding M, et al. Ehealth: Low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol WJG. 2014 Nov 21;20(43):16215–26.
- Gawrońska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther. 2006 Oct 23;25(2):177–84.
- Francavilla R, Miniello V, Magistà AM, De Canio A, Bucci N, Gagliardi F, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2010 Dec;126(6):e1445-1452.
